What top creators are saying about ProKidney Corp.(PROK)
A cell therapy company developing a treatment for kidney disease.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about ProKidney Corp. in the last 30 days yet.
Top creators covering ProKidney Corp. (PROK)
The 1 sources with the most insights about ProKidney Corp. on Kazuha.
Latest insights about ProKidney Corp. (PROK)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Wednesday, July 9, 2025
Presented as a high-conviction short idea due to extreme skepticism about the company's scientific approach, lack of transparency, and a high borrow fee of 126%.
Wednesday, July 9, 2025
Presented as a high-conviction short idea due to extreme skepticism about the company's scientific approach, lack of transparency, and a high borrow fee of 126%.
Discussed alongside ProKidney Corp. (PROK)
Other assets that creators frequently mention in the same content as ProKidney Corp..
Frequently asked
Which podcasters and creators cover ProKidney Corp. (PROK) the most?
The most active sources covering ProKidney Corp. (PROK) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about ProKidney Corp. (PROK) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about ProKidney Corp. (PROK) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside ProKidney Corp. (PROK)?
Creators covering ProKidney Corp. (PROK) most frequently also discuss MSB, IREN, PZIA, QBTS, ARQQ. See the "Discussed alongside" section above for full asset pages.